Table Of Contents

1. Introduction
1.1. Overview Of Europe Injectabledrug Delivery Market
1.2. Currency And Pricing
1.3. Limitation
1.4. Markets Covered
2. Market Segmentation
2.1. Markets Covered
2.2. Geographic Scope
2.3. Years Considered For The Study
2.4. Currency And Pricing
2.5. Research Methodology
2.6. Primary Interviews With Key Opinion Leaders
2.7. Secondary Sources
2.8. Assumptions
3. Market Overview
3.1. Drivers
3.1.1. Rising Cases Of Chronic Diseases
3.1.2. Rising Demand Of Self-Injection Devices
3.1.3. Growth Of Biologics Market
3.1.4. Technological Advancements And Innovations In Drug Delivery Market
3.2. Restraints
3.2.1. Needlestick Injuries And Infections
3.2.2. High Cost Of Development
3.2.3. Strict Regulatory Framework
3.3. Opportunity
3.3.1. Increasing Demand For Generic And Biosimilar Drugs
3.3.1.1. Generics
3.3.1.2. Biosimilars
3.3.2. Increasing Demand For Contraceptive Injectables
3.3.3. Increasing Demand For Self-Administration Of Drugs
3.4. Challenges
3.4.1. Alternative Route Of Drug Administration
3.4.2. Product Recall
3.4.3. Stability Of Products
3.4.4. Sterility Of Injections
4. Executive Summary
5. Premium Insights
6. Europe Injectable Drug Delivery Market, Regulatory
6.1. Overview
6.2. U.S. Fda Approval
6.3. Ce Marking (European Conformity)
6.4. Em (European Medicine Agency)
7. Europe Injectable Drug Delivery Market, By Type
7.1. Overview
7.2. Injectable Drug Delivery Devices
7.2.1. Conventional Injection Devices
7.2.2. Self Injection Devices
7.2.2.1. Needle Free Injectors (Nfi)
7.2.2.2. Auto Injectors
7.2.2.3. Pen Injectors
7.2.2.4. Wearable Injectors
7.3. Injectable Drug Delivery Formulation
7.3.1. Conventional Drug Delivery Formulations
7.3.1.1. Solutions
7.3.1.2. Reconstituted/Lyophilized Formulations
7.3.1.3. Suspensions
7.3.1.4. Emulsions
7.3.2. Novel Drug Delivery Formulations
7.3.2.1. Colloidal Dispersions
7.3.2.2. Microparticles
7.3.2.3. Long Acting Injection Formulation
8. Europe Injectable Drug Delivery Market, By Application
8.1. Overview
8.2. Europe Injectable Drug Delivery Market, By Application
8.3. Hormonal Disorders
8.3.1. Injectable Drugs For Diabetes
8.3.2. Injectable Drugs For Anemia
8.3.3. Injectable Drugs For Reproductive Health Disease
8.3.4. Injectable Drugs For Antithrombotic/Thrombolytic Therapy
8.3.5. Injectable Drugs For Osteoporosis
8.3.6. Injectable Drugs For Growth Hormone Disorders (Ghd)
8.4. Oncology
8.5. Autoimmune Diseases
8.5.1. Injectable Drugs For Rheumatoid Arthritis
8.5.2. Injectable Drugs For Multiple Sclerosis
8.5.3. Injectable Drugs For Crohn?S Diseases
8.5.4. Injectable Drugs For Psoriasis
8.5.5. Injectable Drugs For Other Autoimmune Diseases
8.6. Orphan Disease
8.7. Other Applications
8.7.1. Injectable Drugs For Pain Management
8.7.2. Injectable Drugs For Allergy Treatment
8.7.3. Injectable Drugs For Aesthetic Treatments
8.7.4. Injectable Drugs For Hepatitis C
8.7.5. Injectable Drugs For Hemophilia
9. Europe Injectable Drug Delivery Market, By Usage Pattern
9.1. Overview
9.2. Curative Care
9.3. Immunizations
9.4. Other Usage Pattern
10. Europe Injectable Drug Delivery Market, By Mode Of Administration
10.1. Overview
10.2. Skin
10.3. Circulatory/ Muskoskeletal
10.4. Organs
10.5. Central Nervous System
11. Europe Injectable Drug Delivery Market, By End User
11.1. Overview
11.2. Hospitals And Clinics
11.3. Home Healthcare Settings
11.4. Research Laboratories
11.5. Pharmaceutical And Biotechnological Companies
11.6. Other End Users
12. Europe Injectable Drug Delivery Market, By Distribution Channel
12.1. Overview
12.1.1. Hospital Pharmacy
12.1.2. Pharmacy Stores
12.1.3. Direct Tender
12.1.4. Online Pharmacy
13. Europe Injectable Drug Delivery Market, By Geography
13.1. Overview
12.2. Europe Injectable Drug Delivery Market
12.2.1. Germany Injectable Drug Delivery Market
12.2.2. France Injectable Drug Delivery Market
12.2.3. Uk Injectable Drug Delivery Market
12.2.4. Italy Injectable Drug Delivery Market
12.2.5. Switzerland Injectable Drug Delivery Market
12.2.6. Spain Injectable Drug Delivery Market
12.2.7. Netherland Injectable Drug Delivery Market
12.2.8. Russia Injectable Drug Delivery Market
12.2.9. Turkey Injectable Drug Delivery Market
12.2.10. Belgium Injectable Drug Delivery Market
12.2.11. Rest Of Europe Injectable Drug Delivery Market
14. Europe Injectable Drug Delivery Market, Company Share
14.1. Company Share Analysis; Europe
15. Company Profiles
15.1. Becton, Dickinson And Company
15.1.1. Company Overview
15.1.1.1. Drivers Explained
15.1.1.2. Weaknesses Explained
15.1.1.3. Oppurtunities Explained
15.1.1.4. Threats Explained
15.1.2. Product Portfolio
15.1.3. Recent Developments
15.2. Pfizer
15.2.1. Company Overview
15.2.1.1. Drivers Explained
15.2.1.2. Weaknesses Explained
15.2.1.3. Oppurtunities Explained
15.2.1.4. Threats Explained
15.2.2. Product Portfolio
15.2.3. Recent Developments
15.3. Baxter International
15.3.1. Company Overview
15.3.1.1. Drivers Explained
15.3.1.2. Weaknesses Explained
15.3.1.3. Oppurtunities Explained
15.3.1.4. Threats Explained
15.3.2. Product Portfolio
15.3.3. Recent Developments
15.4. Gerresheimer Ag
15.4.1. Company Overview
15.4.2. Product Portfolio
15.4.3. Recent Developments
15.5. Schott Ag Inc.
15.5.1. Company Overview
15.5.2. Product Portfolio
15.5.3. Recent Developments
15.6. Alkermes Inc.
15.6.1. Company Overview
15.6.2. Product Portfolio
15.6.3. Recent Developments
15.7. Antares Pharma
15.7.1. Company Overview
15.7.2. Product Portfolio
15.7.3. Recent Developments
15.8. Bespak (Subsidiary Of Consort Medical Company)
15.8.1. Company Overview
15.8.2. Product Portfolio
15.8.3. Recent Developments
15.9. Elcam Medical
15.9.1. Company Overview
15.9.2. Product Portfolio
15.9.3. Recent Developments
15.10. Eli Lilly And Company
15.10.1. Company Overview
15.10.1.1. Drivers Explained
15.10.1.2. Weaknesses Explained
15.10.1.3. Oppurtunities Explained
15.10.1.4. Threats Explained
15.10.2. Product Portfolio
15.10.3. Recent Developments
15.11. Haselmeier
15.11.1. Company Overview
15.11.2. Product Portfolio
15.11.3. Recent Developments
15.12. Mylan N.V.
15.12.1. Company Overview
15.12.2. Product Portfolio
15.12.3. Recent Developments
15.13. Novo Nordisk
15.13.1. Company Overview
15.13.2. Product Portfolio
15.13.3. Recent Developments
15.14. Owen Mumford Ltd
15.14.1. Company Overview
15.14.2. Product Portfolio
15.14.3. Recent Developments
15.15. Sandoz International Gmbh
15.15.1. Company Overview
15.15.2. Product Portfolio
15.15.3. Recent Developments
15.16. Sanofi
15.16.1. Company Overview
15.16.2. Product Portfolio
15.16.3. Recent Developments
15.17. Terumo Corporation
15.17.1. Company Overview
15.17.2. Product Portfolio
15.17.3. Recent Developments
15.18. Teva Pharmaceutical
15.18.1. Company Overview
15.18.1.1. Drivers Explained
15.18.1.2. Weaknesses Explained
15.18.1.3. Oppurtunities Explained
15.18.1.4. Threats Explained
15.18.2. Product Portfolio
15.18.3. Recent Developments
15.19. West Pharmaceutical Services, Inc
15.19.1. Company Overview
15.19.2. Product Portfolio
15.19.3. Recent Developments
15.20. Ypsomed Holding Ag
15.20.1. Company Overview
15.20.2. Product Portfolio
15.20.3. Recent Developments
16. Related Reports